Budipine 是抗帕金森病剂的一种。

Budipine is a low affinity, N-methyl-D-aspartate receptor antagonist,is an antiparkinsonian agent.

The primary action of budipine is an indirect dopaminergic effect as shown by facilitation of dopamine (DA) release, inhibition of monoamine oxidase type B (MAO-B) and of DA (re) up-take and stimulation of aromatic L-amino acid decarboxylase (AADC), which in sum might be responsible for enhancing the endogenous dopaminergic activity[1].

57982-78-2

C21H27N

293.454

DMSO:10 mM
Powder: -20°C for 3 years
In solvent: -80°C for 2 years